000 02205 a2200589 4500
005 20250516172430.0
264 0 _c20150413
008 201504s 0 0 eng d
022 _a1941-2703
024 7 _a10.1089/jamp.2013.1040
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDaley-Yates, Peter T
245 0 0 _aPharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
_h[electronic resource]
260 _bJournal of aerosol medicine and pulmonary drug delivery
_cAug 2014
300 _a279-89 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdrenergic beta-2 Receptor Agonists
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aAerosols
650 0 4 _aAged
650 0 4 _aAlbuterol
_xadministration & dosage
650 0 4 _aAndrostadienes
_xadministration & dosage
650 0 4 _aArea Under Curve
650 0 4 _aAsthma
_xdiagnosis
650 0 4 _aBiological Availability
650 0 4 _aBronchodilator Agents
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Combinations
650 0 4 _aDry Powder Inhalers
650 0 4 _aEquipment Design
650 0 4 _aFemale
650 0 4 _aFluticasone-Salmeterol Drug Combination
650 0 4 _aHumans
650 0 4 _aLung
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNew South Wales
650 0 4 _aNew Zealand
650 0 4 _aParticle Size
650 0 4 _aPowders
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xdiagnosis
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aMehta, Rashmi
700 1 _aChan, Robert H
700 1 _aDespa, Simona X
700 1 _aLouey, Margaret D
773 0 _tJournal of aerosol medicine and pulmonary drug delivery
_gvol. 27
_gno. 4
_gp. 279-89
856 4 0 _uhttps://doi.org/10.1089/jamp.2013.1040
_zAvailable from publisher's website
999 _c23124271
_d23124271